Chemokines as Therapeutic Targets in Non-Small Cell Lung Cancer
Journal:
Current Medicinal Chemistry - Anti-Cancer Agents
Volume:
2
Page:
403-417
Author(s):
E.S. White, R.M. Strieter and D.A. Arenberg
Recent Progress in the Development of Anticancer Agents
Journal:
Current Medicinal Chemistry - Anti-Cancer Agents
Volume:
2
Page:
419-439
Author(s):
Sandor Eckhardt
Neopterin as a Marker for Immune System Activation
Journal:
Current Drug Metabolism
Volume:
3
Page:
175-187
Author(s):
C. Murr, B. Widner, B. Wirleitner and D. Fuchs
Physiology of Folic Acid in Health and Disease
Journal:
Current Drug Metabolism
Volume:
3
Page:
211-223
Author(s):
O. Stanger
Docetaxel (Taxotere) in the Treatment of Non-Small Cell Lung Cancer
Journal:
Current Medicinal Chemistry
Volume:
9
Page:
869-877
Author(s):
Vassilis Georgoulias
Vinorelbine in the Treatment of Non-Small Cell Lung Cancer
Journal:
Current Medicinal Chemistry
Volume:
9
Page:
879-891
Author(s):
Cesare Gridelli and Rocco De. Vivo
Neoadjuvant Chemotherapy in Non-Small Cell Lung Cancer
Journal:
Current Medicinal Chemistry
Volume:
9
Page:
893-898
Author(s):
Enriqueta Felip and Rafael Rosell
Preface
Journal:
Current Drug Targets
Volume:
3
Page:
i-i
Author(s):
Ram P. Sharma
Aspartic Proteinases in Disease: A Structural Perspective
Journal:
Current Drug Targets
Volume:
3
Page:
155-173
Author(s):
J. B. Cooper
The Central Role Played by Peptides in the Immune Response and the Design of Peptide-Based Vaccines Against Infectious Diseases and Cancer
Journal:
Current Drug Targets
Volume:
3
Page:
175-196
Author(s):
D. C. Jackson, A. W. Purcell, C. J. Fitzmaurice, W. Zeng and D. N.J. Hart